Salem Erode Investments Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000664,
    "name": "Salem Erode Inv.",
    "stock_name": "Salem Erode Inv.",
    "full_name": "Salem Erode Investments Ltd",
    "name_url": "stocks-analysis/salem-erode-inv",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "41.49",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "41.49",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540181,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE894E01028",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/salem-erode-inv-1000664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Salem Erode Investments Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/salem-erode-investments-faces-severe-selling-pressure-amid-lower-circuit-lock-3748202",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SalemErodeInves_only_sellers_3748202.png",
        "date": "2025-12-05 09:41:33",
        "description": "Salem Erode Investments Ltd is currently experiencing extreme selling pressure, with the stock showing no buying interest and a queue dominated solely by sell orders. This distress selling signals a challenging phase for the Non Banking Financial Company (NBFC), as it continues to underperform against broader market benchmarks over multiple time frames."
      },
      {
        "title": "Salem Erode Investments Q2 FY26: Mounting Losses Signal Deepening Distress",
        "link": "https://www.marketsmojo.com/news/result-analysis/salem-erode-investments-q2-fy26-mounting-losses-signal-deepening-distress-3715239",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SalemErodeInves_quaterlyResult_3715239.png",
        "date": "2025-11-14 09:41:02",
        "description": "Salem Erode Investments Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹47.00 crores, reported another dismal quarter in Q2 FY26, posting a net loss of ₹1.20 crores—a sequential deterioration of 21.21% from Q1 FY26's loss of ₹0.99 crores and a staggering 41.18% worse year-on-year compared to Q2 FY25's loss of ₹0.85 crores. The company's struggles intensified as revenue contracted sharply by 18.35% quarter-on-quarter to ₹0.89 crores, whilst employee costs remained stubbornly elevated at ₹0.90 crores, exceeding total income and pushing operating margins deep into negative territory at -57.30%."
      },
      {
        "title": "How has been the historical performance of Salem Erode Inv.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-salem-erode-inv-3699551",
        "imagepath": "",
        "date": "2025-11-13 23:41:20",
        "description": "Answer:\nThe historical performance of Salem Erode Inv. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods.\n\nBreakdown:\nSalem Erode Inv. reported net sales of 3.85 Cr in March 2025, a decrease from 4.09 Cr in March 2024 and an increase from 4.00 Cr in March 2023. The total operating income mirrored this trend, remaining at 3.85 Cr in March 2025, down from 4.09 Cr in March 2024. The company has seen a substantial rise in total expenditure, which reached 7.28 Cr in March 2025, compared to 5.04 Cr in March 2024 and 3.70 Cr in March 2023. This increase in expenses has led to a significant operating loss, with an operating profit (PBDIT) of -3.38 Cr in March 2025, worsening from -0.90 Cr in March 2024. The profit before tax also declined sharply to -4.95 Cr in March 2025 from -1.77 Cr in March 2024, while profit after tax was -4.72 Cr in March 2025, ..."
      },
      {
        "title": "When is the next results date for Salem Erode Inv.?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-salem-erode-inv-3691198",
        "imagepath": "",
        "date": "2025-11-11 23:19:51",
        "description": "Salem Erode Inv. will declare its results on 13 November 2025...."
      },
      {
        "title": "Is Salem Erode Inv. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-salem-erode-inv-overvalued-or-undervalued-3642525",
        "imagepath": "",
        "date": "2025-10-24 08:12:19",
        "description": "As of 23 October 2025, the valuation grade for Salem Erode Inv. has moved from expensive to risky. The company is currently considered overvalued based on its financial metrics. Key ratios indicate significant concerns, with a PE ratio of -10.70, an EV to EBITDA ratio of -50.98, and a ROE of -22.76%. \n\nIn comparison to its peers, Salem Erode Inv. stands out negatively, especially against Bajaj Finance, which has a PE ratio of 39.07, and Life Insurance, with a PE of 11.68. The company's performance has lagged behind the Sensex, with a year-to-date return of -22.29% compared to the Sensex's 8.21%. Overall, the financial indicators suggest that Salem Erode Inv. is not only overvalued but also presents a risky investment proposition...."
      },
      {
        "title": "Salem Erode Investments Ltd Declines 5.1% Today, Approaches 52-Week Low of Rs 36.56",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/salem-erode-investments-ltd-declines-51-today-approaches-52-week-low-of-rs-3656-3633576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/SalemErodeInves_only_buyers_3633576.png",
        "date": "2025-10-20 09:31:50",
        "description": "Salem Erode Investments Ltd, a microcap in the NBFC sector, is experiencing notable buying activity despite a recent decline in stock performance. The stock has faced consecutive losses and is trading below key moving averages, while the broader market, represented by the Sensex, shows gains."
      },
      {
        "title": "Is Salem Erode Inv. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-salem-erode-inv-overvalued-or-undervalued-3633025",
        "imagepath": "",
        "date": "2025-10-20 08:08:11",
        "description": "As of 17 October 2025, the valuation grade for Salem Erode Investment has moved from risky to expensive. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of -10.14, an EV to EBITDA of -48.61, and a ROE of -22.76%. These figures indicate significant financial distress and a lack of profitability.\n\nIn comparison to its peers, Salem Erode Investment's valuation stands out unfavorably. For instance, Bajaj Finance has a PE ratio of 38.21, while Life Insurance boasts a PE of 11.49, both indicating a healthier financial position relative to Salem Erode. Additionally, the company's stock has underperformed compared to the Sensex, with a year-to-date return of -26.39% versus the Sensex's 7.44%, further reinforcing the notion that Salem Erode Investment is overvalued in the current market environment...."
      },
      {
        "title": "Is Salem Erode Inv. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-salem-erode-inv-overvalued-or-undervalued-3631487",
        "imagepath": "",
        "date": "2025-10-19 08:08:01",
        "description": "As of 17 October 2025, the valuation grade for Salem Erode Inv. has moved from risky to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios reveal a PE ratio of -10.14, an EV to EBITDA of -48.61, and a ROE of -22.76%, all of which suggest significant financial distress and inefficiency.\n\nIn comparison to peers, Salem Erode Inv. stands out unfavorably against companies like Bajaj Finance, which has a PE ratio of 38.21, and Life Insurance, with a PE of 11.49. The stark contrast in valuation metrics highlights the challenges faced by Salem Erode Inv. in the current market landscape. Furthermore, the company's stock has underperformed relative to the Sensex, with a year-to-date return of -26.39% compared to the Sensex's gain of 7.44%, reinforcing the notion of overvaluation amidst declining investor confidence...."
      },
      {
        "title": "Is Salem Erode Inv. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-salem-erode-inv-overvalued-or-undervalued-3630556",
        "imagepath": "",
        "date": "2025-10-18 08:07:45",
        "description": "As of 17 October 2025, the valuation grade for Salem Erode Inv. has moved from risky to expensive, indicating a significant shift in its perceived value. The company is currently overvalued, with a Price to Earnings (PE) ratio of -10.14, an EV to EBITDA ratio of -48.61, and a Return on Equity (ROE) of -22.76%. These ratios suggest that the company is struggling to generate profits and is not performing well relative to its earnings potential.\n\nIn comparison to its peers, Salem Erode Inv. stands out as overvalued when juxtaposed with Bajaj Finance, which has a PE ratio of 38.21, and Life Insurance, which boasts a PE of 11.49. The stark contrast in valuation metrics highlights the relative expense of Salem Erode Inv. within the Non-Banking Financial Company (NBFC) sector. Additionally, the company's stock has underperformed against the Sensex, with a year-to-date return of -26.39% compared to the Sensex's 7.4..."
      }
    ],
    "total": 70,
    "sid": "1000664",
    "stock_news_url": "https://www.marketsmojo.com/news/salem-erode-investments-1000664"
  },
  "announcements": [
    {
      "caption": "Outcome Of The Debenture And Bond Committee Meeting Held On November 15 2025 Of Salem Erode Investments Limited",
      "datetime": "15-Nov-2025",
      "details": "Approved the allotment of 8430 (Eight Thousand Four Hundred Thirty) Unlisted Secured Redeemable Non-Convertible Debentures of face value of Rs.1000 for an aggregate amount of Rs.8430000 on a private placement basis.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Publication of Unaudited Standalone Financial Results for the Quarter and Half Year ended September 30 2025",
      "source": "BSE"
    },
    {
      "caption": "Financial Results On September 30 2025",
      "datetime": "13-Nov-2025",
      "details": "Considered and approved the unaudited Standalone Financial results of the company for the quarter and half year ended September 30 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Salem Erode Investments Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-05 09:41:33

Salem Erode Investments Ltd is currently experiencing extreme selling pressure, with the stock showing no buying interest and a queue dominated solely by sell orders. This distress selling signals a challenging phase for the Non Banking Financial Company (NBFC), as it continues to underperform against broader market benchmarks over multiple time frames.

Salem Erode Investments Q2 FY26: Mounting Losses Signal Deepening Distress

2025-11-14 09:41:02

Salem Erode Investments Ltd., a micro-cap non-banking financial company with a market capitalisation of ₹47.00 crores, reported another dismal quarter in Q2 FY26, posting a net loss of ₹1.20 crores—a sequential deterioration of 21.21% from Q1 FY26's loss of ₹0.99 crores and a staggering 41.18% worse year-on-year compared to Q2 FY25's loss of ₹0.85 crores. The company's struggles intensified as revenue contracted sharply by 18.35% quarter-on-quarter to ₹0.89 crores, whilst employee costs remained stubbornly elevated at ₹0.90 crores, exceeding total income and pushing operating margins deep into negative territory at -57.30%.

How has been the historical performance of Salem Erode Inv.?

2025-11-13 23:41:20

Answer: The historical performance of Salem Erode Inv. shows a fluctuating trend in net sales and profitability over the years, with significant losses in recent periods. Breakdown: Salem Erode Inv. reported net sales of 3.85 Cr in March 2025, a decrease from 4.09 Cr in March 2024 and an increase from 4.00 Cr in March 2023. The total operating income mirrored this trend, remaining at 3.85 Cr in March 2025, down from 4.09 Cr in March 2024. The company has seen a substantial rise in total expenditure, which reached 7.28 Cr in March 2025, compared to 5.04 Cr in March 2024 and 3.70 Cr in March 2023. This increase in expenses has led to a significant operating loss, with an operating profit (PBDIT) of -3.38 Cr in March 2025, worsening from -0.90 Cr in March 2024. The profit before tax also declined sharply to -4.95 Cr in March 2025 from -1.77 Cr in March 2024, while profit after tax was -4.72 Cr in March 2025, ...

When is the next results date for Salem Erode Inv.?

2025-11-11 23:19:51

Salem Erode Inv. will declare its results on 13 November 2025....

Is Salem Erode Inv. overvalued or undervalued?

2025-10-24 08:12:19

As of 23 October 2025, the valuation grade for Salem Erode Inv. has moved from expensive to risky. The company is currently considered overvalued based on its financial metrics. Key ratios indicate significant concerns, with a PE ratio of -10.70, an EV to EBITDA ratio of -50.98, and a ROE of -22.76%. In comparison to its peers, Salem Erode Inv. stands out negatively, especially against Bajaj Finance, which has a PE ratio of 39.07, and Life Insurance, with a PE of 11.68. The company's performance has lagged behind the Sensex, with a year-to-date return of -22.29% compared to the Sensex's 8.21%. Overall, the financial indicators suggest that Salem Erode Inv. is not only overvalued but also presents a risky investment proposition....

Salem Erode Investments Ltd Declines 5.1% Today, Approaches 52-Week Low of Rs 36.56

2025-10-20 09:31:50

Salem Erode Investments Ltd, a microcap in the NBFC sector, is experiencing notable buying activity despite a recent decline in stock performance. The stock has faced consecutive losses and is trading below key moving averages, while the broader market, represented by the Sensex, shows gains.

Is Salem Erode Inv. overvalued or undervalued?

2025-10-20 08:08:11

As of 17 October 2025, the valuation grade for Salem Erode Investment has moved from risky to expensive. The company is currently overvalued based on its financial metrics. Key ratios include a PE ratio of -10.14, an EV to EBITDA of -48.61, and a ROE of -22.76%. These figures indicate significant financial distress and a lack of profitability. In comparison to its peers, Salem Erode Investment's valuation stands out unfavorably. For instance, Bajaj Finance has a PE ratio of 38.21, while Life Insurance boasts a PE of 11.49, both indicating a healthier financial position relative to Salem Erode. Additionally, the company's stock has underperformed compared to the Sensex, with a year-to-date return of -26.39% versus the Sensex's 7.44%, further reinforcing the notion that Salem Erode Investment is overvalued in the current market environment....

Is Salem Erode Inv. overvalued or undervalued?

2025-10-19 08:08:01

As of 17 October 2025, the valuation grade for Salem Erode Inv. has moved from risky to expensive, indicating a shift in perception regarding its market value. The company is currently considered overvalued. Key ratios reveal a PE ratio of -10.14, an EV to EBITDA of -48.61, and a ROE of -22.76%, all of which suggest significant financial distress and inefficiency. In comparison to peers, Salem Erode Inv. stands out unfavorably against companies like Bajaj Finance, which has a PE ratio of 38.21, and Life Insurance, with a PE of 11.49. The stark contrast in valuation metrics highlights the challenges faced by Salem Erode Inv. in the current market landscape. Furthermore, the company's stock has underperformed relative to the Sensex, with a year-to-date return of -26.39% compared to the Sensex's gain of 7.44%, reinforcing the notion of overvaluation amidst declining investor confidence....

Is Salem Erode Inv. overvalued or undervalued?

2025-10-18 08:07:45

As of 17 October 2025, the valuation grade for Salem Erode Inv. has moved from risky to expensive, indicating a significant shift in its perceived value. The company is currently overvalued, with a Price to Earnings (PE) ratio of -10.14, an EV to EBITDA ratio of -48.61, and a Return on Equity (ROE) of -22.76%. These ratios suggest that the company is struggling to generate profits and is not performing well relative to its earnings potential. In comparison to its peers, Salem Erode Inv. stands out as overvalued when juxtaposed with Bajaj Finance, which has a PE ratio of 38.21, and Life Insurance, which boasts a PE of 11.49. The stark contrast in valuation metrics highlights the relative expense of Salem Erode Inv. within the Non-Banking Financial Company (NBFC) sector. Additionally, the company's stock has underperformed against the Sensex, with a year-to-date return of -26.39% compared to the Sensex's 7.4...

View All News